Legal Representation
Attorney
Pamela A. May
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 30, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Apr 30, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 1, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 1, 2008 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 1, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 15, 2008 | RCCK | S | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION | Loading... |
| Jan 24, 2008 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 23, 2007 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 23, 2007 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jul 23, 2007 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 5, 2007 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Jan 5, 2007 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Nov 30, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 8, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 30, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 8, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 8, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 8, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 3, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 9, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
Detailed Classifications
Class 005
PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF INFECTIOUS DISEASES, PAIN, INFLAMMATION, SEPSIS, ALOPECIA AND OBESITY, AND FOR THE TREATMENT OF VIRAL, METABOLIC, MUSCULOSKELETAL, CARDIOVASCULAR, CARDIOPULMONARY, GENITOURINARY, SEXUAL DYSFUNCTION, ONCOLOGICAL, RESPIRATORY, NEUROLOGICAL, GASTROINTESTINAL, HORMONAL, DERMATOLOGICAL AND PSYCHIATRIC RELATED DISEASES AND DISORDERS AND FOR THE TREATMENT OF DAMAGED SKIN AND TISSUE; AND FOR VACCINES
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005